Fig. 6From: An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPDRoc curve analysis of statistically significant compounds. A–N ROC curves constructed for compounds that exhibited the most effective diagnostic performance and a moderate ability to distinguish between these two groups, as measured by an Area under the Curve (AUC) around or greater than 0.7. O Cumulative ROC curve constructed by combining all compounds that showed good/ moderate diagnostic capability. ROC and cumulative ROC curves were acquired by Metaboanalyst softwareBack to article page